Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, and Cancer Treatment and Pharmacology.
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
Cardiac safety and efficacy for patients with early-stage breast cancer treated with pegylated liposomal doxorubicin (PLD) or doxorubicin.
CACA Guidelines for Holistic Integrative Management of Breast Cancer
Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer
Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement
The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018)
miRNA-21 Expression in the Serum of Elderly Patients with Acute Myocardial Infarction
Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer
Impact of emergency percutaneous coronary intervention on outcomes of ST-segment elevation myocardial infarction patients complicated by out-of-hospital cardiac arrest.
PubMed 2012cited by 12position: last